JPMorgan Strategist: Financials Could Boom in H2 2026 on Strong Job Growth
A JPMorgan strategist says financial stocks could lead a late-2026 rally if job growth accelerates and broadens beyon...
When To Choose Index Funds Over Stocks
Knowing when to opt for index funds over stocks helps you prioritize diversification and lower maintenance while pursuing gains.
25,835 articlesStock Market Live July 7, 2026: S&P Drops on Tech Worries
Tech-led selling pushed the S&P 500 lower on July 7, 2026, as AI demand concerns weigh on sentiment and earnings sign...
Reason Cramer Won’t Stop Buying Nvidia Again This Week
Jim Cramer's ongoing Nvidia purchases rest on one core belief: the CUDA software moat that underpins Nvidia's AI lead...
Live: Will Alphabet Smash in Tonight's Q2 Earnings Results
Alphabet reports Q2 results after the bell as traders weigh ad growth, AI monetization, and cloud margins. A volatile...
Phibro Animal Health President Sells Stock After Q2 2026 Strength
When a company posts a robust quarter, insider stock moves often draw attention. This article unpacks the sale by the...
Southwest Gas Keeps 14% Growth Target Through 2030
Southwest Gas missed Q4 earnings by three cents but reaffirmed its 14% annual growth target through 2030, tying the m...
Economy Gained Strength February as ISM PMI Surges Higher
Manufacturing activity rose to a multi-year high in February, suggesting broad economic resilience even as Winter Sto...
Forget Amazon, Hits $100: Walmart Poised to Thrive
Oil approaching $100 per barrel could upend retail economics. Walmart appears best positioned to weather an energy-dr...
Marvell Technology Shares Jump: Is Now the Time to Buy?
Marvell Technology has surged as AI workloads push demand for data-center hardware. This article breaks down the driv...
Arms Race Shifting Again—These Picks and Shovels Shine
Nvidia signals a wave of AI data-center demand, but investors are eyeing Broadcom and ASML as durable infrastructure ...
Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Dividend Kings Brink: Will These Two Lose Crowns in 2026
Two Dividend Kings confront mounting cash-flow pressures and strategic shifts as 2026 approaches. This story examines...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status